Edwards Lifesciences | EW - Operating Profit


Edwards Lifesciences reported $519.5M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 1.36B 775M Sep/2026
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
ICU Medical USD 60.43M 30.05M Jun/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
J&J USD 6.47B 1B Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026